Ticker
CHRSCompany Name
COHERUS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Goodwill and Intangibles | Goodwill & Intangibles to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 439.46M | $ 52.31M | 11.9% |
3/31/2025 | $ 371.07M | $ 52.98M | 14.28% |
12/31/2024 | $ 448.53M | $ 53.65M | 11.96% |
9/30/2024 | $ 505M | $ 54.31M | 10.76% |
6/30/2024 | $ 674.86M | $ 55.45M | 8.22% |
3/31/2024 | $ 763.54M | $ 57.1M | 7.48% |
12/31/2023 | $ 629.6M | $ 71.67M | 11.38% |
9/30/2023 | $ 583.78M | $ 46.52M | 7.97% |
6/30/2023 | $ 469.59M | $ 5.81M | 1.24% |
3/31/2023 | $ 402.43M | $ 5.87M | 1.46% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Intangibles / Assets
(=) Intang. to Assets
Intang. to Assets for COHERUS ONCOLOGY INC is calculated as follows: Intangibles [ $ 3.56M ] / Assets [ $ 803.73M ]
(=) Intang. to Assets [ 0.44% ]
Minimum
Dec 31, 2020
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.23K |
---|---|
min | 0% |
max | 23.1% |
average | 3.98% |
median | 0.51% |
std | 6.08% |